IBI362

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for IBI362, covering 2021-07-23 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity [Phase 3]